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Abstract
Objectives: We sought to determine the frequency and outcomes with symptomatic arrhythmia 
in patients with apical ballooning syndrome (ABS).                                                       
Methods: A retrospective review of the Mayo Clinic Angiography database was conducted to 
identify patients who met the Mayo criteria for ABS. Patients with documented arrhythmias 
formed the study group, and 31 randomly selected patients with ABS but without arrhythmia 
formed   the   control   group.                                                                              
Results:  Out of 105 patients identified with ABS, 6 (5.7%) women aged 69 +/- 9 years 
experienced significant arrhythmia (ventricular fibrillation, asystole), 2 patients died, and 1 
required permanent pacemaker implantation. When compared with controls, the study group 
showed no significant difference with respect to  ECG  characteristics (QT, QRS duration or 
axis) except for   R-R   interval   variability (see comments below) (30.6±6 vs 14.5±17 p = 
0.0004), QTc, and P-R interval. Patients without arrhythmia were more likely to be on  beta-
blocker therapy than the study population (33% vs 80.6% p = 0.02).                                
Conclusion:  Life-threatening arrhythmia is uncommon (5.7%) with ABS despite marked, 
structural abnormalities. When arrhythmias do occur, the outcome is poor.  Prominent variability 
in R-R intervals appears to be predictive of significant arrhythmias in ABS.  The role of beta-
blocker therapy in preventing arrhythmia with ABS requires further investigation. 
Key Words: apical ballooning, Takotsubo cardiomyopathy, arrhythmia, sudden death, 
ventricular fibrillation, atrioventricular block 
Introduction
               Apical   ballooning   syndrome   (ABS)   also   referred   to   as   Takotsubo   or   stress 
cardiomyopathy is characterized by symptoms of myocardial ischemia, ST segment and T wave 
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abnormality along with transient ventricular wall motion abnormalities in the absence of 
significant  coronary  artery  stenosis1,2.  There  have been   anecdotal  reports   for  significant 
arrhythmias in patients with ABS3,4, but the exact association, if any, of ABS with malignant 
arrhythmias is unknown. While ABS shares several similarities with acute coronary syndromes 
including QT interval prolongation and increased QT dispersion in the subacute phase5, life-
threatening arrhythmias and permanent conduction abnormalities appear to be less common.  
            Several studies comparing ABS with myocardial ischemia have found similarities in the 
ST segment and T wave changes including the time course of these changes in both sets of 
patients. An important distinction in the electrocardiographic findings between myocardial 
ischemia in ABS was recently reported6. Rate adaptation of ventricular repolarization, that is, the 
dynamicity of QT interval modulation in response to changes in heart rate, appears to be 
preserved in patients with ABS but is significantly affected in patients with myocardial 
infarction.  
            The aim of our study was to determine the incidence, significance, and outcomes of 
malignant brady- and tachyarrhythmia in patients with a definitive diagnosis of ABS. We further 
explored the potential contribution of the lack of effect of 24-hour R-R interval   variability  on 
repolarization.
Materials   and   Methods                                                                          
Study   population                                                                              
               The Mayo Clinic Cardiac Catheterization database was retrospectively reviewed to 
identify patients who underwent coronary arteriography and left ventriculography and met the 
Mayo Clinic criteria (Table 1)7 for diagnosis of ABS from January 1988 to November 2003. In 
addition, patients were enrolled prospectively from November 2003 to October 2006. We 
initially   identified   550   patients   without   obstructive   coronary   disease   and   wall   motion 
abnormality sparing the basal segments. Out of 550 patients, 421 were excluded because of a 
diagnosed cardiomyopathy, valvular disease, congenital heart disease, phaeochromocytoma, 
cocaine abuse, paced heart rhythm, or active myocarditis. Of the remaining 129 patients, 107 
met the Mayo Clinic criteria for diagnosis of ABS7 with documented complete normalization of 
left ventricular function on follow-up echocardiography, 2 patients could not be contacted, and 
the remaining 105 patients formed the study population.  
Table 1: Mayo Clinic Criteria for the Clinical Diagnosis of Apical Ballooning Syndrome
*Rare exceptions to these criteria exist. †The possibility of ABS developing along with obstructive coronary 
atherosclerosis may rarely need consideration.                                                                 
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In either of the above circumstances, the diagnosis of apical ballooning syndrome should be 
made with caution, and evidence for a clear stressful precipitating figure must be sought.  
Data   collection                                                                                    
               The   complete   medical   record   with   particular   emphasis   on   historical   features, 
medications, and 12-lead electrocardiograms were reviewed in the study population.                
               Initial echocardiography was performed without knowledge of patient outcome or 
eventual diagnosis.   Each echocardiogram of the patients in this series was reviewed by an 
independent echocardiologist who was blinded to patient outcome in this study. All diagnoses 
based on the echocardiographic features were found by both echocardiologists to be consistent 
with   ABS.                                                                                                    
Electrocardiographic analysis                                                                                 
            Manual measurement of the P wave duration, PR, QT, and R-R intervals were made. 
Bazett's formula was used to calculate the corrected QT interval8. QT variability was measured 
as the absolute difference in the QT interval in lead V1 from the QT interval in lead V6. This 
was done to understand the regional variation in repolarization given the regionality of wall 
motion abnormality in patients with ABS.  The PR interval was indexed to the heart rate to 
discount the potential effect of heart rate variation on AV nodal conduction. Each patient had a 
minimum of four electrocardiograms analyzed of which at least 1 was in the first 24 hours 
following diagnosis. Holter monitoring, telemetry, and other electrocardiographic data, when 
available, were analyzed. R-R interval variability was determined as the difference between the 
maximum and minimum heart rate during the 24 hours following diagnosis of ABS.  
Study   and   control   group                                                                          
            Six patients with ABS were identified with life- threatening arrhythmia and formed the 
study group, and 31 patients were randomly selected from the remaining 99 patients without a 
fatal or life-threatening arrhythmia and formed the control group. The electrocardiographic 
parameter review and analysis was performed in a blinded fashion as to whether or not the 
patient had malignant arrhythmia.                                                                                    
            The cause of death was confirmed using all available clinical data at the time of death 
and by reviewing the issued death certificates.  The study was approved by the Mayo Clinic 
Institutional Review Board for Human Research and included only patients who gave consent 
for their medical records to be utilized for research.                                                               
Statistical   analysis                                                                                      
            Descriptive statistics are reported as frequencies and percentages for categorical data and 
the mean ± standard deviation for continuous data.  Comparisons between patient groups were 
performed with the Student t test for independent, categorical variables.  Follow-up events are 
reported as individual occurrences and estimated  using the Kaplan-Meier method where 
applicable.   
 
Results
Study   group                                                                                                  
            Out of 105 patients with ABS (5.7%), 6 were found to have life- threatening arrhythmias 
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and formed the study group.  All patients were females with mean age of 69 ± 8.9 years (Table 
2). Salient features include the average heart rate at presentation 89 ± 26.8 bpm, P wave duration 
100 ± 20 ms, PR interval 207 ± 96 ms, PR index 2.1 ± 1.4 ms/beat, QT interval 405 ± 85 ms, 
QTc 491 ± 81 ms, QT dispersion 78 ± 40.2 ms, regional QT variability (QT in lead V6 – QT in 
lead V1) 11 ± 23.4, and maximal 24-hour R-R interval variation 30.6 ± 6 ms (Table 3). The 
median and interquartile range from time from onset of symptoms to ECG was 100 and 
12.5-338.5 minutes.
Table 2: ABS and Malignant Arrhythmia: Patient Characteristics
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Table 3: Malignant Arrhythmia and ABS: Risk Factors
            Out of the 6 patients who presented with ventricular fibrillation, 2 were first diagnosed 
with  ABS following resuscitation. Patient 1 had sinus pauses at presentation with ABS up to 7.4 
seconds in duration. The clinical course was later complicated by asystole requiring resuscitation 
that included temporary pacemaker implantation and inotropic support with gradual clinical 
improvement.  Patient 2 had a documented cardiac arrest 4 days after diagnosis with ABS. The 
QTc was 399 ms 3 hours prior to her arrest. The patient did have a prior history of atrial 
fibrillation but was not monitored  electrocardiographically at the time of cardiac arrest. 
Ventricular fibrillation was documented during attempted resuscitation that failed with the 
patient dying.  Patient 3  had a prior history of multifocal atrial tachycardia and pacemaker 
implantation and presented with ventricular fibrillation. The patient recovered completely and 
was discharged home uneventfully 9 days following diagnosis but died following sudden cardiac 
arrest 3 days following hospital discharge. Patient 4 presented with unexplained collapse and 
documented ventricular fibrillation. Following resuscitation, a diagnosis of ABS was made. The 
patient   gradually  improved   and   was   discharged   with   subsequent  complete   normalization 
echocardiographically and clinically at 7 months post episodes. Patient 5 presented with anginal 
chest pain, and admission  ECG  showed Mobitz I AV block and right bundle-branch block at 
the time of diagnosis with ABS.  One week following hospitalization, worsening of Mobitz I 
block along with evidence of sinus node dysfunction was found. EP study showed no evidence 
of infra-Hisian conduction disease. The patient had completely recovered but with persisting 
right bundle-branch block and Mobitz I AV block 16 months following ABS diagnosis. Patient 
6 had electrocardiographically documented Mobitz II AV block with ventricular rate of 32 bpm. 
Permanent pacemaker implantation was performed, and the remainder of her hospital course was 
uneventful with complete recovery of wall motion abnormalities at follow-up up to 7 years 
following   initial   diagnosis.                                                                                    
Control   group                                                                                                
            Thirty-one patients with diagnosed ABS without significant arrhythmia constituted the 
control group. All patients were female with mean age of 68.2 +/- 12 years, average heart rate of 
86.5 +/- 21 bpm, PR interval of 162 +/- 24 ms, QT interval of 366.4 +/- 52 ms, QTc interval of 
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433.7 +/- 25 ms, and maximal 24-hour R-R interval variation of 14.5 +/- 17 ms. The median and 
interquartile range from time from onset of symptoms to ECG was 240 and 5-870 minutes.
Differences in study and control groups                                                  
               In comparing the patients with and without malignant arrhythmia, there was no 
statistically significant difference in the heart rate at presentation (89±26.8 vs 86.5±21.2, p = 
0.8), P wave axis (73.3±13.3 vs 57.6±17.7, p = 0.1), QT interval (405.3±84.7 vs 366.4±52.3, p = 
0.1), QT index (4.55±6.39 vs 5.09±10.41, p = 0.9), QT dispersion (78±40.2 vs 63.3±26.7, p = 
0.2), regional QT variability (11±23.4 vs 15.5±34.1, p = 0.8), PR index ( 2.1±1.4 vs 1.95±0.6, p 
= 0.5), or time of onset of symptoms to ECG (median 100 vs 240, p = 0.2) (Figure 1).
Figure 1: Upper panel:  There was no significant difference in the baseline QT interval between patients with ABS 
with and without malignant arrhythmia.   However, the corrected QT interval was significantly different, being 
higher in the patients with arrhythmias (see text for details). Lower panel:  There was a significant difference in the 
PR interval in the study versus control group.  The PR interval was longer in patients with arrhythmia and ABS.  
When the PR interval was indexed for the heart rate, there was no difference in the two groups.  This suggests that 
at higher sinus rates, the PR interval shortened in ABS patients with arrhythmias.  This in turn suggests that the 
cause of AV delay was at the level of the compact AV node, and conduction improved during catecholamine stress 
(see text for details).
            There was a statistically significant difference between these 2 groups in maximal R-R 
interval variation (30.6±6 vs 14.5±17, p = 0.0004), QTc interval (490.5±80.8 vs 433.7±25.4, p = 
0.0025), and PR interval (207±95.9 vs 162±24.3, p = 0.02) (Figure 2).  
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Figure 2: The maximal R-R interval variation at first evaluation was significantly greater in patients who developed 
life-threatening arrhythmia when compared to the control group with ABS and no significant arrhythmia. This 
finding, coupled with our observation of longer corrected QT interval in the study group suggests potential 
mechanism for arrhythmogenicity in ABS patients who developed documented malignant arrhythmia.  
            Clinical characteristics at baseline were similar in the control and study groups (age, sex, 
hypertension, diabetes). Patients in the study group, however, had a higher prevalence of atrial 
fibrillation (66.6% vs 9.6% p = 0.001) and were less likely to be on beta-blocker therapy at the 
time of presentation (2/6 [33.3%] vs. 25/31 [80.6%] p = 0.02).                               
Discussion
    
            Since its recent description as a clinical entity characterized by transient ventricular 
dysfunction in the setting of chest pain, ST segment, and T wave abnormalities in the absence of 
occlusive coronary artery disease, apical ballooning syndrome has become the subject of 
significant investigation1,2,5,6. While important advances have been made in understanding the 
extent of myocardial involvement1,2, potential pathogenic mechanisms, and distinctions with 
ischemic syndromes1,3,5,6, little is known about the risk and outcomes associated with arrhythmia 
(bradycardic and tachycardic) occurring in the setting of ABS.                                
            Previous reports have shown that although the type of changes in the 12-lead surface 
electrocardiogram and the time course of these ECG  changes in ABS are similar to those seen in 
patients with a myocardial infarction5,9,  malignant arrhythmias are much less common in ABS. 
Matsuoka et al5 reported the absence of sudden cardiac death and other malignant ventricular 
arrhythmia in patients with ABS even though electrocardiographic abnormality including 
significantly prolonged QT intervals and QT dispersion persisted for several weeks after the 
index event. A few prior reports have, however, demonstrated occasional apparent association 
between ABS and both significant bradyarrhythmia and tachycardia3,4.                           
            In our study population of 105 patients diagnosed with ABS based on Mayo Clinic 
criteria,   6   patients   (5.7%)   experienced   life-threatening   arrhythmia   and/or   conduction 
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abnormality. There was no significant difference in these patients with malignant arrhythmia 
compared to a control population (ABS without arrhythmia) with regard to clinical presentation, 
age,   sex   and   other   clinical   parameters.   We   did,   however,   find   several   important 
electrocardiographic   and   previous   history   differences   that   may   provide   clues   to   the 
pathophysiology of ABS and point to treatment options to decrease risks of these arrhythmias.   
Maximal RR interval variation                                                                                         
            We report that patients with ABS who had malignant arrhythmia had significantly more 
variation in their R-R intervals (maximal R-R interval - minimum R-R interval in the first 24 
hours of admission) compared with the control group. A recent report by Bonnemeier et al6 may 
help explain our findings. In their study6, patients with ABS continued to show modulation of 
the QT interval with changes in the heart rate even during the acute phase of the syndrome. This 
was in contradistinction to the absence of such modulation in patients with myocardial 
infarction10. Thus, when malignant arrhythmias occur in myocardial infarction, they are likely as 
a result of ischemia itself, whereas in apical ballooning syndrome should a patient have prior QT 
prolongation or have significant heart rate variation, they would likely have more prominent QT 
interval changes that may increase the propensity for malignant arrhythmia (Figure 3).  
Figure 3: All patients in the study and control group met our published criteria for ABS.  Although all patients had 
the typical transient ST segment and T wave changes at the time of documented wall motion abnormality, patients 
who developed malignant arrhythmia had greater variation in the R-R intervals along with a longer corrected QT 
interval (see text for details).  
Prior   arrhythmia                                                                                            
            We found a significant increase in prior arrhythmia in patients with ABS who developed 
malignant arrhythmia. Three patients had prior atrial fibrillation, and 1 patient each with 
multifocal atrial tachycardia, variable AV node dysfunction, and sinus node dysfunction. Each of 
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these conditions increases the variability of ventricular activation (variable heart rate). As 
discussed above, with the recently demonstrated continued presence of QT modulation with 
heart rate variation,  these prior  arrhythmias  may  have contributed  to the study group's 
predilection for malignant arrhythmia.                                                                            
PR   and   QT   intervals                                                                  
            In our study, we found a statistically significant difference in the PR intervals between 
the 2 groups, yet there was no difference once we corrected for heart rate (PR index).  Thus, the 
patients with the longer PR intervals had concomitant slower heart rates.  This finding suggests 
that   the  PR   prolongation   is   not   from  intrinsic   AV   nodal  conduction   disease   but  from 
sympathovagal imbalance as a previously suggested abnormality in ABS11. Structural AV nodal 
disease   as   potentially   from   transient   disturbances   in   the   microcirculation   as   previously 
suggested4 would have resulted in longer PR intervals at faster heart rates and is contrary to our 
finding. We further found evidence in our 2 patients with AV block that support a predominant 
catecholamine surge is important in the pathogenesis of ABS. In the patient with Mobitz I AV 
block and EP study proven absence of intra-Hisian conduction disease, there appeared to be 
transient improvement in AV conduction in the acute phase of the syndrome. On the other hand, 
in the patient with Mobitz II AV block (infra-Hisian), the condition was worsened in the acute 
phase. This type of response in AV block is consistent with catecholamine stimulation12.    
    
            We also found in our study that the QT interval corrected for heart rate (QTc) was 
significantly longer in patients at risk for malignant arrhythmia even though the absolute QT 
interval showed no difference.  This finding suggests that in our study group, the longer QT 
interval occurred in patients with relatively faster heart rates, a finding similar to that observed in 
ischemic heart disease.   As discussed previously, because of the preserved QT modulatory 
defects of heart rates in ABS6 (as opposed to its absence in ischemic heart disease), this may 
have further contributed to arrhythmogenesis seen in our patients with marked rate variability. A 
second explanation may be that because the malignant arrhythmias occurred in our patients with 
marked variation in their heart rate, the standard correction for QT intervals at extremes of heart 
rate may have been inaccurate. It is possible that in a few patients who had cardiac arrest or other 
severe medical illness/dyselectrolytemia that the QTc at the time of the measurement used in our 
study may have been affected. Whenever possible, pre-event (cardiac arrest) electrograms were 
used   to  obtain   baseline  data.                                                                                
Beta-blocker   use                                                                                    
            An unanticipated finding in our study was the statistically significant difference in beta-
blocker use in the study group 2/6 (33.3%) versus the control group 25/31 (80.6%), p value 
0.02.  While this result should be interpreted with caution given the relatively small number of 
patients in the study group, it nevertheless is consistent with the hypothesis that marked variation 
in heart rate may be the primary factor increasing the risk for malignant arrhythmia in patients 
with ABS.   If further studies also show such a protective effect of beta-blockers, then 
recommending these drugs for long-term use following recovery may be considered given the 
nonnegligible recurrence rate for ABS (11.4% at 4-year follow-up1).                                         
               Another incidental finding of potential significance from our study was the higher 
prevalence of atrial fibrillation (66% vs. 9.6%, p=0.001) in the study group with malignant 
arrhythmia compared to the control group. Based on the above discussion on preserved QT 
dynamicity in ABS patients, the reason for this increased prevalence of atrial fibrillation may be 
as a result of prominent R-R interval variability from this disease, in turn producing significant 
ventricular arrhythmia. Alternative possibilities include preexisting conduction abnormalities in 
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patients with atrial fibrillation (sick sinus syndrome) or a previously unproven association of 
atrial fibrillation with ABS.                                                                                        
            Thus, while our study shows that malignant arrhythmias are uncommon in patients with 
ABS, they do occur, and marked heart rate variability and previously diagnosed arrhythmia may 
be risk factors for their development while beta-blocker use may be protective. Our study was 
too small to comment on ICD benefit. However, in one patient who had a resuscitated event, 
secondary prophylaxis could have been considered and may have prevented his event.  
   
Limitations
            A portion of our study was conducted in a retrospective fashion, and thus some data 
relevant to arrhythmias may have not been collected at the time of diagnosis. We did perform, 
however, a careful chart review and all saved electrocardiographic and rhythm monitoring data 
to try and offset this weakness in our study.                                                                                      
            We used the simple difference between maximal and minimal R-R intervals during 24-
hours to assess for R-R interval variability in our study. A more robust method of looking at 
heart rate variability would have been superior given the importance of this finding in our study. 
However, similar measurements in both the control and study group were made in a blinded 
fashion, thus the reported association is likely accurate.                                        
               Another limitation of our study is that we have grouped arrhythmias of varying 
pathophysiology as malignant arrhythmias and defined our study group accordingly. The 
majority of the patients did have ventricular fibrillation, but as noted in our discussion, AV nodal 
block may accentuate the propensity for ventricular arrhythmia as well.  In addition, our findings 
that prior beta-blocker use was protective and that marked R-R interval variability was predictive 
of arrhythmic events regardless of whether these were tachyarrhythmic or bradyarrhythmic 
constituted the rationale for this grouping.                                                                                            
            In our study, we excluded many patients (421/550 [76.5%]) with likely ABS when a 
concomitant cardiac diagnosis (dilated cardiomyopathy, etc.) was present. In practice, patients 
with these previous comorbidities may develop ABS, and the risk factors for malignant 
arrhythmia and possible protective effect of beta-blockade may be different from our findings.  
Conclusion
            To our knowledge, this is the first report in a relatively large series of confirmed ABS 
patients on the occurrence of malignant arrhythmias specifically comparing patients with such 
arrhythmias with control patients with ABS but without clinical arrhythmia.  We found that 
marked 24-hour R-R interval variation and prior history of arrhythmia increased the propensity 
for malignant arrhythmia in patients with ABS, and beta-blocker use decreases the risk of such 
arrhythmia.  
            If future, larger studies confirm these observations, then more careful monitoring of 
patients with ABS, prior arrhythmia, and marked heart rate variation is warranted, and beta-
blocker use can be recommended particularly in anticipation of possible recurrent ABS.  
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